NIH-funded research R01 grant

Generating specialized cells for blood vessel development

Official title: A Novel Transcription Factor-Driven Approach for Mural Progenitor Cells Generation

Funded at Boston Children's Hospital · NIH-11085071 · Data updated 2026-11-12

This study is looking at how to turn special stem cells into important cells that help keep our blood vessels healthy, which could lead to better treatments for blood vessel problems and help with healing and repairing tissues.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 7, 2024
Project endApril 30, 2028
Funding year2025
Award (this year)$574,306
NIH project number5R01HL172968-02
Project IDNIH-11085071 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to vascular abnormalities or those interested in regenerative therapies.

Less likely to help

Patients with stable vascular health or those not affected by blood vessel disorders may not benefit from this research.

What this research studies

This research focuses on creating mural progenitor cells, which are essential for the development and stability of blood vessels. By utilizing human induced pluripotent stem cells (iPSCs), the researchers aim to develop a method that allows for the precise differentiation of these cells using specific transcription factors. This approach could lead to new therapies for vascular disorders and improve tissue repair and regenerative medicine. The study will explore how these progenitor cells can mature into fully functional mural cells, which play a critical role in blood vessel health.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments for patients with vascular disorders and enhance regenerative medicine techniques.

How similar studies have gone: Previous research has shown success in generating vascular cells from iPSCs using transcription factors, indicating a promising avenue for this novel approach.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Melero-Martin, Juan M — Boston Children's Hospital
  • Study coordinator: Melero-Martin, Juan M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.